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Abstract
Background: Serum retinol concentration determined by high-performance liquid chromatography (HPLC) is
recommended by the World Health Organization to assess population vitamin A status. This assay is expensive,
technically demanding and rarely available in developing countries. Our objective was a) to assess the diagnostic
performance of proxy markers in detecting vitamin A deficiency and b) to derive decision rules based on these
markers to estimate vitamin A deficiency prevalence.
Methods: A survey was conducted in 15 rural primary schools in Eastern Province, Kenya, with 375 children aged
6 to 12 years (25 randomly selected per school). Serum retinol concentration <0.70 μmol/L by HPLC was used to
define vitamin A deficiency. Proxy markers for vitamin A deficiency were serum concentrations of retinol binding
protein (RBP), transthyretin, retinol measured by fluorometry and RBP:transthyretin molar ratio.
Results: The prevalence of vitamin A deficiency (HPLC) was 18%. Transthyretin and RBP showed the best diagnostic
performance individually, with area-under-the-curve (AUC) values of 0.96 and 0.93. When combined, and with C-reactive
protein added, the AUC increased to 0.98. A simple decision rule {(−15.277 × [RBP, μmol/L] - 7.013 × [Transthyretin,
μmol/L] + 0.367 × [C-reactive protein, mg/L] + 24.714) > 0.496} yielded prevalence estimates of vitamin A deficiency
that is unbiased by diagnostic error.
Conclusions: The combination of transthyretin, RBP and C-reactive protein concentrations could eventually replace
retinol concentration by HPLC in resource-poor settings as the preferred method to assess the population burden of
vitamin A deficiency.
Keywords: Vitamin A deficiency, Discriminant analysis, ROC curve, Sensitivity and specificity, Predictive value of tests,
Retinol, Retinol binding protein, Transthyretin, Inflammation, Diagnosis
Background
A serum retinol (vitamin A) concentration of ≤0.70 μmol/L
is recommended by the World Health Organization
as a marker to assess the population burden of vitamin
A deficiency [1,2]. Its measurement requires high-
performance liquid chromatography (HPLC), which is
expensive, technically demanding and rarely available in
developing countries [3]. In addition, measurement of
serum retinol concentration typically requires venipuncture
to obtain the blood volume (>500 μL) necessary, and sam-
ples must be stored in tubes impermeable to light until
laboratory analysis.
Several serum indicators proposed as proxy markers of
vitamin A status may be conveniently used in resource-
poor settings. These include retinol binding protein
(RBP) concentration, the molar ratio of RBP:transthyre-
tin and retinol concentration measured by fluorometry
[4]. RBP is a transporter protein that binds, transports
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and delivers retinol to target organs. Its secretion from the
liver, where it is produced, into the circulation depends on
circulating retinol levels [5]. Studies in rats suggest that
RBP is present in serum in a 1:1 molar ratio to retinol,
but surveys in humans indicate that this ratio can be
different and is influenced by inflammation, protein-
energy malnutrition, obesity, vitamin A status, iron status
and pregnancy [6]. Thus the molar concentration of retinol
in serum can differ from that of RBP.
Transthyretin is involved in transport of retinol through
the formation of a complex with RBP and retinol, which
prevents the glomerular filtration of the RBP molecule in
the kidneys [7,8]. The molar ratio of RBP:transthyretin
has been proposed as an indicator of vitamin A status
unaffected by inflammation [9]. Both RBP and trans-
thyretin can be measured relatively easily by enzyme-linked
immunosorbent assay (ELISA). Fluorometry exploits the
characteristic of retinol to fluoresce under the influence of
ultraviolet light, particularly when bound to RBP [10,11],
allowing its measurement using a point-of-care test under
field conditions.
To our knowledge, no studies have evaluated the diag-
nostic performance of combinations of these proxy markers
to assess vitamin A status, and few studies have considered
the effect of diagnostic error on prevalence estimates of
vitamin A deficiency. The present study, conducted among
Kenyan children, aimed to assess the diagnostic perform-
ance of the proxy markers listed above, alone or in combin-
ation, in detecting vitamin A deficiency defined as serum
retinol concentration <0.70 μmol/L (measured by HPLC)
[2]. In this analysis, we considered inflammation markers,
age, body mass index for age z-score and iron status as
additional diagnostic markers. Secondly, we aimed to derive
decision rules based on these markers to estimate the
prevalence of vitamin A deficiency.
Methods
Subjects and sample collection
The study was approved by ethical committees in Kenya
and the Netherlands. We conducted a survey (June 2010)
at 15 primary schools in Kibwezi and Makindu Districts in
Eastern Province, Kenya, which had been selected from 45
public schools based on size (>350 children aged 6 to
12 years) and having no school feeding program. For each
school, we randomly selected 25 children from an enrol-
ment list of all children aged 6 to 12 years (n = 375), and
we included those who were apparently healthy and with-
out fever (ear drum temperature <37.5°C) upon examin-
ation by the research physician, and whose guardians had
provided prior informed consent. Venous blood (6 mL)
was obtained from each fasted child and kept shielded
from light at 2 to 8°C for 30 to 60 min. After centrifugation
(1200 g, 10 min), the serum was kept for 4 to 8 h at 2 to
8°C and subsequently stored in liquid nitrogen (−196°C)
in Kenya, and at −80°C during transport and storage in
the Netherlands. Blood samples were obtained by finger
prick to measure haemoglobin concentration (HemoCue,
Ängelholm, Sweden). Weight and height were measured
according to WHO guidelines [12] to the nearest 0.1 kg
and 0.1 cm using a mechanical floor scale and a portable
stadiometer (Seca, Hamburg, Germany).
Biochemical analyses
Concentrations of retinol (by HPLC), RBP and ferritin were
determined at Wageningen University, the Netherlands
(August 2010). Samples used to measure retinol concentra-
tions were processed under subdued yellow light.
We added 200 μL sodium chloride (0.9% w/v in water)
and 400 μL 96% ethanol, containing retinyl acetate as an
internal standard, to 200 μL serum. Serum samples were
extracted twice with 800 μL hexane for 5 min using a
horizontal laboratory shaker (Edmund Buehler, model
SM25, Heckingen, Germany) at 250 reciprocations/min,
and then centrifuged for 2 min at 3000 g. The hexane
supernatants were pooled into an HPLC vial. Twenty-
five μL of the extract was injected directly into a polar
BDS Hypersil CN HPLC column (150 × 3 mm inner
diameter, particle size 5 μm) with a Javelin NH2 guard
column (both from Keystone Scientific, Bellefonte PA,
USA). The HPLC system (Spectra, Thermo Separation
Products Inc., San Jose CA, USA) was equipped with
two pumps (model P2000), a solvent degasser (model
SCM400), a temperature-controlled auto sampler (model
AS3000), a UV-visible forward optical scanning detector
(UV3000), interface (model SN4000) and control and
integration software (Chromquest 5.0). As eluent, we used
a mixture of hexane-isopropanol (98.5%:1.5% v/v) contain-
ing triethylamine (0.1% v/v) as a mobile phase additive to
reduce peak tailing, at a constant flow of 0.7 mL/min.
Separations were measured at 325 nm and quantified
using the internal standard method against retinol stan-
dards. The total runtime was 5 min. Within-run and
between-run coefficient of variations (CV) were 1.6% and
2.1%, respectively, based on in-house control serum. Ana-
lysis of standard reference material SRM 968e from the
National Institute of Standards and Technology (NIST,
Gaithersburg, MD, USA) revealed deviations of 0.3%, 0.2%
and 5% from certified values for the low, medium and
high levels (1.19 μmol/L, 1.68 μmol/L and 2.26 μmol/L,
respectively). Duplicate measurements were done on 10%
of samples, resulting in a mean CV of 2.0%.
RBP concentrations were determined by immunoassay
(catalogue DRB400, Quantikine, R&D Systems, Minneapolis,
USA). Results were read in duplicate for 10% of samples.
The inter-plate CV for six plates was 10.4%. The intra-
assay CV for duplicate samples was 6.0%.
Ferritin concentrations were determined by enzymatic
immunoassay (Ramco Laboratories, Stafford, TX, USA).
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Results were read in duplicate for 10% of samples. The
inter-plate CV for six plates was 8.8%. The intra-assay
CV for duplicate samples was 9.7%.
A point-of-care fluorometer (iCheck™ FLUORO; BioAna-
lyt, Teltow, Germany) was validated (see online Additional
file 1) and used (September 2011) to measure concen-
trations of vitamin A (retinol and retinyl palmitate) at exci-
tation and emission wavelengths of 330 nm and 470 nm.
Children were ranked on serum retinol concentration and
a subset of 105 samples was selected by taking every third
sample. If the sample was insufficient, the next sample
on the list was taken to ensure the same concentration
range. 250 μL of serum was injected into a sealed glass
cuvette prefilled with a proprietary reagent (IEX™ MILA,
BioAnalyt) comprising a mixture of alcohols and organic
solvents. 250 μL of phosphate buffered saline solution
(PBS) was added to obtain the required 500-μL sample
volume and the result was multiplied by two. Samples
were measured according to manufacturer guidelines.
Control samples provided by the manufacturer were
measured at the beginning and end of each batch of
measurements and were within the expected range.
Serum concentrations of transthyretin, C-reactive pro-
tein and α1-acid glycoprotein were determined by immu-
noturbidimetric assays on a Cobas Integra 800 system
(Roche Diagnostics, Mannheim, Germany) at University
Medical Centre, Leiden, The Netherlands (October 2010).
The transthyretin concentration was measured using
the PREA assay (Roche), with CVs of 1.9% and 3.2% at
concentrations of 4.7 μmol/L and 11.4 μmol/L. The C-
reactive protein concentration was measured by Tina-
quant ultrasensitive assay (Roche), with CVs of 1.8% and
1.9% at concentrations of 3.98 mg/L and 12.81 mg/L. The
α1-acid glycoprotein concentration was measured using
the Tina-quant AAGP2 assay (Roche), with CVs of 1.3%
and 0.5% at concentrations of 0.77 g/L and 1.27 g/L.
Statistical analyses
Anthropometric z-scores were calculated using Anthro-
plus (WHO, version 3.2.2). The results were analysed
using the statistical software packages IBM SPSS 20.0
and STATA 12. Comparisons were done separately for
all children and for those without inflammation, defined
as serum concentrations of C-reactive protein <5 mg/L
or α1-acid glycoprotein <1 g/L [13]. Distributions of serum
markers were inspected by visual examination of histo-
grams, and were described using conventional methods.
We defined vitamin A status by serum retinol concentra-
tion (HPLC) <0.70 μmol/L (deficient) or ≥ 0.70 μmol/L
(replete) [2]. Scatter plots and linear regression analysis
were used to assess linearity in associations of the proxy
markers with serum retinol concentration. Receiver oper-
ating characteristic (ROC) curves were used to assess the
diagnostic accuracy of proxy serum markers in detecting
vitamin A deficiency, whether alone or in linear combina-
tions in comparison with retinol by HPLC. Diagnostic
accuracy was determined by visual inspection of these
curves and by assessing differences in the area under
the curve (AUC) with corresponding P-values. A Bland-
Altman plot was used to assess the agreement between
measuring retinol concentration by HPLC and fluores-
cence [14].
Combinations of proxy markers may have better ability
than single markers to distinguish between children with
and without vitamin A deficiency. For pairs of markers,
we assessed this distinguishing ability by visual inspection
of scatter plots, with individuals being classified by vitamin
A status. Logistic regression was used to assess the added
diagnostic value of each marker and to produce linear
predictors (combinations of diagnostic test results), which
can be interpreted as decision rules to classify vitamin A
status. Each newly defined linear predictor was used to
compute the probability of vitamin A deficiency for all
subjects, which can be considered on its own as the
quantitative outcome of a new, stand-alone diagnostic
test. Thus, we produced ROC curves by allowing this
probability to vary within the range [0, 1]. Using a stepped-
forward selection procedure, we started the model with the
best proxy marker when used alone, and successively added
other proxy markers, serum markers of inflammation, age,
body mass index-for-age z-score and iron status as explana-
tory variables. We settled on a parsimonious model that
only included markers found to have independent diagnos-
tic value when used in combination with others, as judged
by P-values for logistic regression coefficients.
We used two methods to assess the diagnostic accuracy
of this parsimonious model. First, we assessed its good-
ness of fit by assessing the level of agreement between the
probability of vitamin A deficiency as estimated by the
model versus the actually observed frequencies. Thus, we
ordered individuals and grouped them into deciles based
on the predicted probability of vitamin A deficiency as
derived from the logistic regression model, and plotted
the mean predicted value in each decile against the fre-
quency of vitamin A deficient cases that was actually
observed in each decile. The resulting plot should ideally
have a slope of 1 and an intersect of 0.
Second, we assessed the ability of the model to discrim-
inate between children with or without vitamin A defi-
ciency by means of an ROC plot and its AUC. With this
model, we calibrated the value of the linear predictor to
produce prevalence estimates of vitamin A deficiency that
are unbiased by diagnostic error.
Given a diagnostic test with a binary outcome, a set of
paired values for sensitivity and specificity exists that
leads to a prevalence estimate that is identical to the true
prevalence (Figure 1). The intersection of this set and
the ROC curve obtained with our parsimonious logistic
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regression model indicates the value of the linear pre-
dictor (and thus the diagnostic decision rule) that
would result in a prevalence estimate of vitamin A defi-
ciency that is unbiased by diagnostic error. We cali-
brated the linear predictor to estimate the prevalence of
vitamin A deficiency, with true prevalence arbitrarily se-
lected as 6% and 15%, the mid-points for the ranges that
indicate mild and moderate public health problems (2 to
10% and 10 to 20%, respectively) [2]. Similarly, we used
30% and 40% as an arbitrarily selected prevalence in the
range (>20%) indicating a severe public health problem.
Results
Complete data were collected for 372 children; for three
children, no blood sample could be obtained. The fre-
quency distribution of serum retinol at baseline is shown
in online Additional file 1. Table 1 shows the character-
istics of the total study population and the subsample
(n = 105) for which retinol concentration was measured
by fluorometry. Vitamin A deficiency occurred in 18%
of children. Only 10% had inflammation; their exclusion
from analysis led to similar estimates for concentrations
of retinol (whether HPLC or fluorometry), RBP, trans-
thyretin, RBP:transthyretin molar ratio and prevalence
of vitamin A deficiency.
In univariate analysis, retinol measured by HPLC was
strongly associated with RBP and transthyretin, and to a
lesser degree with retinol measured by fluorometry and
the RBP:transthyretin molar ratio (Figure 2).
Figure 3 shows the ROC plots for each proxy marker.
The AUC was the highest for transthyretin and RBP
(0.96 and 0.93, respectively), followed by retinol by
fluorometry (0.81) and RBP:transthyretin molar ratio
(0.56). Excluding children with inflammation resulted
in a slight decrease in AUC for RBP and a slightly higher
AUC for transthyretin and retinol by fluorometry, but did
Figure 1 Elimination of diagnostic error when estimating the prevalence of vitamin A deficiency.
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not appreciably change for the RBP:transthyretin molar
ratio.
The Bland-Altman plot (Figure 4) shows a mean differ-
ence of 0.083 μmol/L between the HPLC and fluorescence
methods, with limits of agreement of −0.40 μmol/L and
0.57 μmol/L. The results of the two methods diverged with
serum retinol concentration, indicating that the fluores-
cence method tended to overestimate concentrations.
Logistic regression resulted in a model of vitamin A
deficiency dependent on RBP, transthyretin and C-reactive
protein and a linear predictor of (−15.277 × [RBPμmol/L] -
7.013 × [Transthyretinμmol/L] + 0.367 × [C-reactive pro-
teinmg/L] + 24.714). Figure 5 illustrates that the observed
versus the predicted probability of vitamin A deficiency
were close to the line of identity, showing an excellent fit
of the model. When used in combination, RBP and trans-
thyretin were better at discriminating between children
with and without vitamin A deficiency than when trans-
thyretin was used alone (AUC: 0.98 versus 0.96; P = 0.01)
or when RBP was used alone (AUC: 0.98 versus 0.93;
P = 0.001) (Figure 3). Addition of C-reactive protein into
the RBP and transthyretin model resulted in a marginal
improvement of AUC but did not improve the model
(AUC: 0.982 versus 0.979; P = 0.44). Figure 6 shows the
decision rules-derived prevalence estimates for vitamin A
deficiency, at true prevalence values of 6%, 15%, 30% and
40%, and the corresponding sensitivity and specificity
values.
Discussion
Serum concentrations of transthyretin and RBP, when
used alone, performed well in discriminating between
children with and without vitamin A deficiency. The test
performance was even better when these markers were
used in combination, and addition of serum C-reactive
protein concentration could lead to further improvement,
albeit marginally. We have shown how these three
markers can be combined to estimate the prevalence of
Table 1 Characteristics of the study population
Main study All children Children without inflammation1
n 372 336
Age, years 9.2 (1.9) 9.2 (1.9)
Sex, girls:boys 199:173 (54%:46%) 180:146 (54%:46%)
Serum retinol concentration by HPLC, μmol/L 0.87 (0.19) 0.88 (0.18)
Vitamin A deficiency1 68 [18%] 49 [15%]
Serum RBP concentration, μmol/L 0.67 (0.17) 0.68 (0.17)
Serum transthyretin concentration, μmol/L 3.0 (0.62) 3.0 (0.60)
RBP:transthyretin molar ratio 0.23 (0.04) 0.23 (0.04)
Serum C-reactive protein concentration >5 mg/L 17 [5%] 0 [0%]
Serum α1-acid glycoprotein concentration >1 g/L 33 [9%] 0 [0%]
Inflammation 2 36 [10%] 0 [0%]
Haemoglobin concentration, g/L 130 (11) 129 (12)
Serum ferritin concentration, μg/L (median, IQR) 19.8 (12.8, 30.2) 19.2 (12.0, 29.5)
BMI for age z-score −1.29 (0.91) −1.29 (0.89)
Sub-study
n 105 94
Age, years 8.9 (1.9) 8.9 (1.9)
Sex, girls:boys, 64:41 (61:39) 58:36 (62:38)
Serum retinol concentration by HPLC, μmol/L 0.87 (0.18) 0.88 (0.17)
Serum retinol concentration by fluorescence, μmol/L 0.79 (0.30) 0.79 (0.30)
Serum C-reactive protein concentration >5 mg/L 4 [4%] 0 [0%]
Serum α1-acid glycoprotein concentration >1 g/L 10 [10%] 0 [0%]
Inflammation2 11 [11%] 0 [0%]
Haemoglobin concentration, g/L 130 (10) 130 (10)
Serum ferritin concentration, μg/L (median, IQR) 18.9 (11.4, 29.4) 18.2 (11.2, 27.7)
BMI for age mean z-score −1.43 (0.91) −1.43 (0.89)
Values indicate mean (SD) or n [%] unless indicated otherwise.
1Serum retinol concentration (HPLC) <0.70 μmol/L. 2Defined by serum concentrations of C-reactive protein >5 mg/L or α1-acid glycoprotein >1 μg/L.
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vitamin A deficiency in population surveys, based on a
simple decision rule to determine individual vitamin A
status.
The strong points of our study are: a) the novel use of
combinations of multiple markers to determine vitamin
A status; b) the relatively large sample size; c) the fact
Figure 2 Associations of four proxy markers with serum retinol
concentration (HPLC). A: RBP, B: transthyretin, C: RBP:transthyretin
molar ratio, D: retinol by fluorescence.
Figure 3 ROC curves for proxy markers of vitamin A deficiency.
Figure 4 Bland-Altman plot of retinol by HPLC versus
fluorescence. The difference between serum retinol concentrations
obtained by HPLC and fluorometry (plotted on Y-axis) indicates by
how much the former method is likely to differ from the latter method.
The mean of these measurements (X-axis) is the best estimate of the
true value, without assuming that one method is superior to the other.
Assuming that the differences between results obtained with these
methods are normally distributed, 95% of the differences will lie within
the range that is indicated by the dotted lines.
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that the study population concerned children for whom
vitamin A status is to be determined (as opposed to chil-
dren with signs or symptoms suggesting deficiency, which
may lead to biased estimates of diagnostic performance);
d) the fact that the study goes beyond an assessment of
diagnostic accuracy as indicated by sensitivity and spe-
cificity but demonstrates the application of a diagnostic
strategy using these markers for public health purposes
(estimation of the prevalence of deficiency).
Although transthyretin has been used as a vitamin A
marker in many studies, it has mostly been analysed as the
RBP:transthyretin molar ratio. Only one study reported
the diagnostic performance of transthyretin [15], but it
was based on univariate analysis and used the relative
dose–response test as a reference, which had been
questioned earlier as a valid indicator of vitamin A
status [16]. Our results suggest that two to three proxy
markers (serum concentrations of RBP, transthyretin
and C-reactive protein) could replace serum retinol
concentration measured by HPLC, with the advantages
that these markers can be conveniently measured at
relatively low cost by separate or multiplex ELISAs, and
require only a small blood volume collected by finger
puncture. Although transthyretin seems stable at refriger-
ated or frozen conditions for up to several weeks [17],
additional studies are required to assess its stability under
field conditions. Although serum C-reactive protein con-
centration had limited diagnostic utility in this study, we
note that it may be more important in populations with
higher prevalence and levels of inflammation. Our results
indicate that the RBP:transthyretin molar ratio is inferior
and should not be used.
Serum retinol concentration measured by fluorometry
is also inferior, but its diagnostic utility may need re-
assessment if the technology can be improved. The greatest
divergence between retinol concentrations as measured
by HPLC and those measured by fluorescence were at
high concentrations, which suggests that our fluorescence
results were affected for some children by retinyl esters
derived from food. Such esters are not detected by our
HPLC method, but they can increase fluorescence read-
ings. We cannot exclude the possibility that some parents
ignored our request to bring children in a fasted state.
Selection of cut-points for dichotomised diagnostic tests
should depend on diagnostic aims. Vitamin A deficiency is
defined by serum retinol concentrations <0.70 μmol/L
because individuals who meet this criterion are considered
to be at increased risk of morbidity and mortality [2]. To
avoid missing cases, it may be desirable for a diagnostic
test to have a high sensitivity in detecting such individuals,
even at the expense of specificity. Another approach
can be to maximise accuracy, i.e., the probability that
individuals with and without vitamin A deficiency are
correctly classified, which is appropriate if a false nega-
tive is considered to be equally undesirable as a false
positive. In the present paper, our diagnostic aim was
to estimate the prevalence of vitamin A deficiency with-
out bias due to diagnostic error. Selection of cut-points
to maximise either sensitivity or accuracy will lead to
overestimates of the true prevalence. When the true
prevalence of vitamin A deficiency is low, the validity
of the estimate depends almost entirely on specificity,
and the optimal cut-point is one for which specificity is
increased even at the expense of sensitivity.
These principles are illustrated in Figure 6, which shows
theoretical conditions whereby combinations of values for
sensitivity, specificity and true prevalence give prevalence
estimates without bias due to diagnostic error (straight
lines). However, the paired values of sensitivity and specifi-
city that can be actually achieved with the combined use
of three proxy markers (RBP, transthyretin and C-reactive
protein) is indicated by the ROC curve. The intersect of
the ROC curve and the straight lines determine the
cut-point for the linear predictor that gives a prevalence
estimate without bias due to diagnostic error. Interpret-
ation of this linear predictor is relatively straightforward.
For example, at a true prevalence of vitamin A deficiency of
15%, individuals for whom (−15.277 × [RBPμmol/L] - 7.013 ×
[Transthyretinμmol/L] + 0.367 × [C-reactive proteinmg/L] +
24.714) > 0.496 should be classified as deficient, whereas all
others can be classified as replete (in this formula, concen-
trations are indicated in straight brackets and expressed in
units as indicated). Such classification may serve as the
basis to compute the prevalence estimate.
Figure 5 Goodness of fit of the model in predicting vitamin A
deficiency. Predicted probability values are grouped in ten equal
deciles based on increasing predicted probability values. Out of
these ten groups, only six can be seen, as four groups contain the
same predicted probability of 0 and overlap each other in
this figure.
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We arbitrarily selected prevalence values of 6%, 15%,
30% and 40% as the mid-points for the ranges that indi-
cate vitamin A deficiency as a mild, moderate or severe
public health problem, and allowed the optimal cut-
point for our linear predictor to vary accordingly. These
cut-points enable national surveys to assess population
vitamin A status at a lower cost and with more accuracy.
Further research is needed to confirm whether this
linear predictor yields valid results in different populations
and laboratories.
It should be noted that prevalence estimates obtained
using our method depend on a priori presumed values.
This dependency is similar to clinical practice, where
interpretation of test results from individual patients ne-
cessarily depends on the a priori presumed probability of
disease. We believe, however, that our method yields more
accurate results than those obtained when diagnostic in-
accuracy is not taken into account.
Conclusions
We conclude that the combination of transthyretin, RBP
and C-reactive protein showed good diagnostic performance
in assessing vitamin A deficiency and has great potential
to eventually replace serum retinol concentration mea-
sured by HPLC as the preferred method to assess the
Figure 6 ROC curve of the best model to predict vitamin A deficiency with its decision rules during different prevalence rates of
vitamin A deficiency. True prevalence was arbitrarily selected as 6%, 15%, 30% and 40% as the mid-points for the ranges that indicate mild,
moderate and severe public health problems (2-10% and 10-20%, >20% respectively). Note that, with the true prevalence decreasing, the optimal
cut-point for the linear predictor results in increased specificity even at the expense of sensitivity. For example, at a true prevalence of vitamin A
deficiency of 15%, individuals for whom (−15.277 × [RBPμmol/L] - 7.013 × [Transthyretinμmol/L] + 0.367 × [C-reactive proteinmg/L] + 24.714) > 0.496
should be classified as deficient, whereas all others can be classified as replete (in this formula, concentrations are indicated in straight brackets,
and expressed in units as indicated).
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population burden of vitamin A deficiency. Our meth-
odology can be widely applied for other diagnostic aims.
Additional file
Additional file 1: Frequency distribution of serum retinol
concentration AND Validation of fluorescence method.
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